Venkatesh Gavini, M. Srinivasa Murthy, P. K. Kumar
Jun 28, 2014
Citations
0
Influential Citations
4
Citations
Journal
Research Journal of Pharmaceutical Dosage Forms and Technology
Abstract
Stavudine (D4T, thymidine) is an FDA-approved drug for clinical use in the treatment of HIV infection, AIDS and AIDS-related conditions either alone or in combination with other antiviral agents. The stavudine has a very short half life (0.8 to 1.5hr) with rapid absorption. The side effects of stavudine are dose dependent and a reduction of the total administered dose reduces the severity of the toxicity. Stavudine is typically administered orally as a capsule and oral solution. Dosage forms that are retained in the stomach would increase the absorption, improve drug efficiency and decrease dose requirements.